These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Positron emission tomography radioligands for dopamine transporters and studies in human and nonhuman primates. Volkow ND; Fowler JS; Ding YS; Wang GJ; Gatley SJ Adv Pharmacol; 1998; 42():211-4. PubMed ID: 9327881 [No Abstract] [Full Text] [Related]
5. Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? For. Tatsch K Eur J Nucl Med Mol Imaging; 2002 May; 29(5):711-4. PubMed ID: 11976813 [No Abstract] [Full Text] [Related]
6. Evaluation of [11C]RTI-121 as a selective radioligand for PET studies of the dopamine transporter. Hume SP; Luthra SK; Brown DJ; Opacka-Juffry J; Osman S; Ashworth S; Myers R; Brady F; Carroll FI; Kuhar MJ; Brooks DJ Nucl Med Biol; 1996 Apr; 23(3):377-84. PubMed ID: 8782251 [TBL] [Abstract][Full Text] [Related]
7. Development of imaging agents for the dopamine transporter. Carroll FI; Scheffel U; Dannals RF; Boja JW; Kuhar MJ Med Res Rev; 1995 Sep; 15(5):419-44. PubMed ID: 8531503 [No Abstract] [Full Text] [Related]